Arteris Q1 revenue $12.9M, ACV up 6% to $58.2M, net loss $9.4M; positive free cash flow

Arteris, Inc.

2024-Q1 EPS reported -$0.25 revenue$12,947,000

Revenue $12.9M; ACV+TTM royalties $58.2M (+6% YoY); RPO $74.7M (+30% YoY).
Net loss $9.4M ($0.25/share); Non-GAAP net loss $5.6M ($0.15/share).
Positive free cash flow $0.3M (2.2% of revenue); Non-GAAP operating loss $5.3M.
Five deals with top-30 tech firms; half of license deals enabled AI/ML design starts.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Arteris, Inc. reported the first quarter ended March 31, 2024 results: revenue $12.9 million, net income $9.4 million or $0.25 per share. Guidance reaffirmed.

Period: the first quarter ended March 31, 2024
Revenue: $12.9 million
Net income: $9.4 million or $0.25 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Arteris' continued influence as a leading commercial system IP vendor in the semiconductor industry,” concluded Janac. First Quarter 2024 Financial Highlights: • Revenue of $12.9 million • Annual Contract Value (ACV) and trailing-twelve-months (TTM) variable royalties of $58.2 million , up 6% year-over-year • Remaining performance obligation (RPO) of $74.7

View on SEC.gov

269 earnings releases filed in the last 30 days. Browse all earnings releases →

Arteris, Inc. filing history →

Source: SEC EDGAR

accession 0001667011-24-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.